FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Par Recalls 7 Treprostinil Lots

Endos Par Pharmaceutical recalls seven lots of treprostinil injection 20g/20mL due to the potential for the presence of silicone particulates in the p...

latest-news-card-1
Federal Register

Info Collection on FDA Social/Behavioral Research

Federal Register notice: FDA seeks comments on an information collection extension entitled Data To Support Social and Behavioral Research as Used by ...

latest-news-card-1
Human Drugs

PhRMA Wants More Feedback on Innovative Trials

Pharmaceutical Research and Manufacturers of America urges FDA to hold more meetings on innovative clinical trial approaches to allow more discussion ...

latest-news-card-1
Medical Devices

Draeger Recalls Perseus Anesthesia Device

Draeger Medical recalls its Draeger Perseus A500 Anesthesia Workstation due to the potential for an unexpected shutdown while operating on battery pow...

latest-news-card-1
Human Drugs

Boxed Warning Ordered on CAR T-Cell Therapies

FDA orders a Boxed Warning to highlight the serious risk of T cell malignancies following administration of BCMA-directed or CD-19-directed autologous...

Medical Devices

Cochlear Osia Cleared for Younger Children

FDA clears a Cochlear 510(k) to lower the patient age for its Cochlear Osia System from 12 years to five years for children with conductive hearing lo...

latest-news-card-1
Biologics

Alvotech/Tevas Stelara Biosimilar Approved

FDA approves Alvotech and Teva Pharmaceuticals Selarsdi (ustekinumab-aekn) injection for subcutaneous use, a biosimilar to Johnson & Johnsons Stelara....

latest-news-card-1
Human Drugs

Takedas Entyvio OKd for Crohns Maintenance

FDA approves Takedas Entyvio (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohns dis...

latest-news-card-1
Medical Devices

AdvaMed Seeks Clarification on Ethnicity Data in RWE

The Advanced Medical Technology Association says FDAs draft guidance on diversity plans for clinical trials needs to address what sponsors should do i...

latest-news-card-1
Human Drugs

Rinvoq Shows Promise in Arteritis: AbbVie

AbbVie reports positive top-line results from SELECT-GCA, a Phase 3, placebo-controlled study that showed the companys arthritis drug Rinvoq (upadacit...